PAMELA BARIOLA: Open Payments
NPI 1598800237 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 43 payments from 18 companies in 2025. Trend: 2023 $890 · 2024 $1,197 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Novo Nordisk Inc | 6 | $125 |
| SANOFI-AVENTIS U.S. LLC | 4 | $86 |
| Lilly USA, LLC | 4 | $77 |
| Corcept Therapeutics | 3 | $67 |
| Abbott Laboratories | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $34 |
| Recor Medical Inc | 2 | $30 |
Products named: TZIELD, Wegovy, Korlym, FARXIGA, MOUNJARO, REXULTI, FREESTYLE LIBRE 3, Kerendia.
Industry payments across TN — which companies pay providers there.
